Vancouver, BC – May 6, 2016 – Aspect Biosystems is pleased to announce the appointment of Tamer Mohamed as President and Chief Executive Officer effective May 3, 2016. As one of Aspect’s co-founders, Mr. Mohamed has played a critical role in the company’s overall corporate, business, and technology development. In his previous appointment as Chief Technology Officer of the company, Mr. Mohamed drove the innovation and development of the company’s core technologies and intellectual property. He was integral to the company’s research and development and is a co-inventor of all of Aspect’s patents. Mr. Mohamed was also heavily involved in the company’s research collaborations and partner and customer engagements.
“I would to like recognize Dr. Konrad Walus’s outstanding contributions and leadership of the company to date,” says Mr. Mohamed. “Konrad will continue to play a key role in the company moving forward.”
“I am honoured and humbled to serve as Aspect Biosystems’ President & CEO and to lead such an excellent team. I look forward to taking the company’s commercialization efforts to the next level and leading Aspect Biosystems in becoming the global leader in 3D human tissue technology.”
Dr. Walus, who is also an Associate Professor at UBC in the Department of Electrical and Computer
Engineering, has led the company and founding team from an idea in the lab to become one of Canada’s most exciting and internationally-recognized startup companies. Dr. Walus will serve as the company’s new Chief Technology Officer effective May 3, 2016.
“It has been an honour and privilege to have served as Chief Executive Officer of Aspect for its first two years,” says Konrad. “I am incredibly proud of our team and the exciting achievements that the company has made. We are positioning Aspect for long-term success and I am very excited about my new role as Chief Technology Officer going forward.”
Mr. Mohamed earned his B.A.Sc. in Biomedical Engineering and M.A.Sc. in Electrical and Computer Engineering at UBC. While completing his M.A.Sc. degree, he co-founded Aspect Biosystems. He started his Ph.D. in Electrical and Computer Engineering at UBC, but left the program to pursue his entrepreneurial ambitions and focus his efforts on building and growing Aspect Biosystems.
About Aspect Biosystems
Founded in November 2013, Aspect Biosystems is an award-winning biotechnology company operating on the leading edge of 3D bioprinting and tissue engineering. Aspect has developed a disruptive 3D bioprinting platform based on its proprietary Lab-on-a-Printer™ technology capable of creating living Human Tissues on Demand™ for broad applications in the life sciences.
Connect with Aspect Biosystems via Twitter (@aspectbiosys), Facebook and LinkedIn.